Kistorp Caroline, Bliddal Henning, Goetze Jens P, Christensen Robin, Faber Jens
Department of Endocrinology, Medicine O, Endocrine Unit, Herlev University Hospital, Herlev Ringvej 75, Herlev, DK-2730 Denmark ; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Copenhagen, Denmark ; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
BMC Obes. 2014 Dec 2;1:24. doi: 10.1186/s40608-014-0024-2. eCollection 2014.
Cardiac natriuretic peptides are established biomarkers in heart disease, but are also affected by body mass index (BMI). The purpose of the present study was to examine the impact of weight loss and changes in body composition following dietary intervention on plasma concentrations of the prohormones to A- and B-type natriuretic peptides (proANP and proBNP) and adrenomedullin (proADM).
A total of 52 healthy obese subjects, 47 women and 5 men (BMI 36.5 ± 5.6 kg/m(2)) were randomised to either an intensive weight reduction programme using a combination of very low calorie diet (810 kcal/day) and conventional hypo-energetic diet (1200 kcal/day) for 52 weeks, or to a control group that was offered diet-related counselling. N-terminal proBNP (NT-proBNP), mid-regional proANP (MR-proANP) and proADM (MR-proADM) and body composition using dual-energy x-ray absorptiometry (DEXA) scanning were determined at baseline and after 52 weeks. Comparisons between groups were analysed using t-tests. Changes from the baseline within the groups were analysed with paired tests. Changes in the variables, delta (∆), were calculated as 52 weeks minus the baseline. In the intervention group, BMI decreased by almost 20% (31.6 ± 6.2 vs. 37.1 ± 6.1 kg/m(2); P <0.001) with a loss of body fat of 23.5 ± 15.5% (P < 0.001). Plasma concentrations of NT-proBNP and MR-proANP increased (from 55 ± 31 to 97 ± 55 pg/ml; P < 0.001, and from 59 ± 21 to 74 ± 26 pmol/L; P < 0.001), whereas MR-proADM decreased (from 573 ± 153 to 534 ± 173 pmol/L; P <0.001). Changes (Δ) in MR-proANP correlated with Δfat mass (r = -0.359; P = 0.011) and Δglucose (r = -0.495; P <0.001), while increases in NT-proBNP were primarily associated with reduced plasma glucose (r = -0.462; P <0.001). A modest but significant weight loss of 6% (P < 0.001) was found in the control group with no changes in plasma concentrations of NT-proBNP or MR-proANP, and a minor change in MR-proADM.
Plasma NT-proBNP and MR-proANP concentrations increase and MR-proADM concentration decreases during weight loss, underlining the dynamic impact of BMI, body composition and glucose metabolism on these cardiovascular biomarkers.
心脏利钠肽是心脏病的确立生物标志物,但也受体重指数(BMI)影响。本研究的目的是探讨饮食干预后体重减轻及身体成分变化对A、B型利钠肽原激素(proANP和proBNP)及肾上腺髓质素(proADM)血浆浓度的影响。
共52名健康肥胖受试者,47名女性和5名男性(BMI 36.5±5.6kg/m²)被随机分为两组,一组接受强化减重计划,采用极低热量饮食(810千卡/天)和传统低热量饮食(1200千卡/天)联合方案,为期52周;另一组为接受饮食相关咨询的对照组。在基线及52周后测定N末端proBNP(NT-proBNP)、中段proANP(MR-proANP)和proADM(MR-proADM),并采用双能X线吸收法(DEXA)扫描测定身体成分。组间比较采用t检验。组内基线变化采用配对检验分析。变量的变化值(∆)计算为52周值减去基线值。干预组BMI下降近20%(31.6±6.2 vs. 37.1±6.1kg/m²;P<0.001),体脂减少23.5±15.5%(P<0.001)。NT-proBNP和MR-proANP血浆浓度升高(从55±31至97±55pg/ml;P<0.001,以及从59±21至74±26pmol/L;P<0.001),而MR-proADM下降(从573±153至534±173pmol/L;P<0.001)。MR-proANP的变化(∆)与脂肪量变化(r=-0.359;P=0.011)和葡萄糖变化(r=-0.495;P<0.001)相关,而NT-proBNP升高主要与血糖降低相关(r=-0.462;P<0.001)。对照组体重适度但显著下降6%(P<0.001),NT-proBNP或MR-proANP血浆浓度无变化,MR-proADM有轻微变化。
体重减轻期间,血浆NT-proBNP和MR-proANP浓度升高,MR-proADM浓度降低,突出了BMI、身体成分和葡萄糖代谢对这些心血管生物标志物的动态影响。